What are the challenges in cell and gene therapy (CGT) development? 🔎 A significant challenge in CGT development is the lack of adequate infrastructure for temperature-controlled storage. Only a small percentage of studies require ultra-low temperature storage, making many researchers hesitant to engage in CGT research. Additionally, maintaining a closed-loop supply chain is critical for CGT. 🌡️ Cryoport Systems addresses this by offering advanced storage facilities and expertise, ensuring the integrity and compliance of stored materials. ❄️ Find out more below! ⬇️ https://lnkd.in/dUeDS9XG #biopharma #healthcareinnovation #advancedtherapies #medicalresearch #biotechindustry #pharmalogistics #coldchainlogistics #biotechnews #therapeuticdevelopment
Labiotech.eu’s Post
More Relevant Posts
-
Thoughts on this? >> SAPA-GP Hosted the Third @Philly Cell and Gene Therapy Annual Conference - The Bakersfield Californian >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #competitivemarketing #pharma #biotech
Google News
bakersfield.com
-
Scaling cell and gene therapies (CGTs) from lab to market has many challenges. Discover how platform technologies, like CellPort, help to address these challenges in our latest blog, featuring insights from European Pharmaceutical Manufacturer. https://lnkd.in/eYNtNBAy
-
-
Thoughts on this? >> SAPA-GP Hosted the Third @Philly Cell and Gene Therapy Annual Conference - Milton Daily Standard >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #competitivemarketing #pharmaceutical #pharma
Google News
standard-journal.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> SAPA-GP Hosted the Third @Philly Cell and Gene Therapy Annual Conference - Milton Daily Standard >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #competitivemarketing #biotech
Google News
standard-journal.com
-
BOOK YOUR FREE SEAT FOR THIS WEBINAR Evaluating Analytical Strategies to Quantify Capsid Titre: Towards a Platform-Method Approach to Accelerate AAV Drug Product Development Presented by Dr. Marília Barros, PhD, Principal Scientist Biologics & Gene Therapy Drug Product Development at Regeneron and Dr. Matthew Ranaghan, Senior Applications Scientist, at Refeyn #highthroughputcapsidtitremethods #HTP #orthogonalcapsidtitremethods #serotypes #INDenablingpreclinicalstudies #firstinhumanclinicalstudies #FIH #Biologics #GeneTherapyDrugProducts #GeneTherapy #Pharma #Biotech #CMC #drugproduct #formulationdevelopment #molecularmass #molecularmassmeasurement #proteins #nucleicacids, #viruses #massphotometry #macromassphotometry #viralvectors #AAVDrugProduct #AnalyticalStrategies #Biopharmawebinars https://lnkd.in/ekV3aVFC
-
-
Thoughts on this? >> GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ® Gene Therapy ... - Joplin Globe >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #competitivemarketing #pharma #pharmaceutical
Google News
joplinglobe.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Taysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcript - Seeking Alpha >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #pharmaceutical #competitivemarketing
Google News
seekingalpha.com
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT ... - Yahoo Finance >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #competitivemarketing #healthcare
Google News
finance.yahoo.com
-
#cdmo #CGTs "Viewed as disruptive to traditional therapies, biotech’s are prioritizing CGTs [cell and gene therapies] development, driving the need for robust cold chain solutions. Many are partnering with contract drug manufacturing organizations (CDMOs) to enhance supply chain efficiency and access new markets. In turn, CDMOs are investing in innovative technologies to support this growing demand..." https://lnkd.in/efsZSXBM
How CDMO’s are addressing cold chain needs with specialized solutions
fiercepharma.com
-
Thoughts on this? >> Luke Roberts, MBBS, PhD, on Challenges in Developing Gene Therapy for Heart Failure - CGTLive™ >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #biotech #competitivemarketing
Google News
cgtlive.com
